Association of angiotensin converting enzyme gene (I/D) polymorphism with hypertension and type 2 diabetes

Bratislava Medical Journal

Volumn 113, Issue 1, 2012, Pages 14-18

  Zarouk, W A ^a   Hussein, I R ^a   Esmaeil, N N ^a   Raslan, H M ^a   Reheim, H A A ^b   Moguib, O ^a   Emara, N A ^a   Aly A A , ^a   Hamed, M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Angiotensin converting enzyme; Hypertension; Polymorphism; Type 2 diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 84871843683     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2012_003     Document Type: Article

References (32)

1. Alberti KG, Zimmet PZ. Defi nition,diagnosis and classifi cation of diabetes mellitus and its complications. Part 1 diagnosis and classifi cation of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
2. Arfa I, Abid A, Nouira S, Elloumi-Zghal S, Malouche S, Mannai I, Zorgati M, Benalaya N, Rebai A, Zouari B. Lack of association between the angiotensin- converting enzyme gene (I/D) polymorphism and diabetic nephropathyin Tunisian type 2 diabetic patients. Journal of Renin - Angiotensin - Aldosterone System 2008; 9 (1): 32-36.
3. Barbalic M, Skaric-Juric T, Cambien F. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens 2006; 19: 837-842.
4. Barley G, Blackwod A, Miller M et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the rennin-angiotensin system in cauvasian and Afro-Caribbean peoles. J Hum Hypertens 1996; 10: 31-35.
5. Bhavani BA, Padma T, Sastry BKS, Krishna-Reddy N, Nausheen K.The insertion/deletion polymorphism of ACE gene increase the susceptibility to hypertension and/or diabetes. Int J Hum Genet 2005 ;5:247 - 252
6. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996; 27: 62-66.
7. Cardoso RL, Nogueira AR, Salis LH, Urmenyi TP, Silva R, Moura-Neto RS, Pereira BB, Rondinelli , Silva NE. The association of ACE gene D/I polymorphism with cardiovascular risk factors in a population from Rio de Janeiro. Brazilian Journal of Medical and Biological Research 2008; 41: 512-518.
8. Chmaisse HN, Jammal M, Fakhoury H, Fakhoury R. A study on the association between angiotensin-I converting enzyme I/D dimorphism and type-2 diabetes mellitus. Saudi J Kidney Dis Transpl 2009; 20 (6): 1038-1046.
9. Dell'omo G, Penno G, Pucci L, Lucchesi D, Fotino C, Del Prato S et al. ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension. Clin Sci 2006; 111: 357-364.
10. Dietze GJ, Henriksen EJ. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.. J Renin Angiotensin Aldosterone Syst 2008; 9 (2): 75-88.
11. Di Pasquale P, Cannizzaro S, Scalzo S. Cardiovascular effects of I/D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years. Acta Cardiol 2005; 60:427-435.
12. Fava S, Azzopardi J, Ellard S, Hattersley AT. ACE Gene Polymorphism as a Prognostic Indicator in Patients With Type 2 Diabetes and Established Renal Disease Diabetes Care 2001; 24: 2115-2120.
13. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes. 2002;51 :1986-1988.
14. Forrester T, McFarlane-Anderson N, Bennett FI, Wilks R, Cooper R, Rotimi C, Morrison L, Ward R. The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 1997; 10: 519-524.
15. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shin-tani M, Fukuda M, Ogihara T. Meta-analysis of association of insertion/ deletion polymorphism of angiotensin 1-converting enzyme gene with diabetic nephropathy. Diabetologia1998; 41: 47-53 .
16. Grammer TB, Renner W, Von Karger S, Boehm BO, Winkelmann BR, Maerz W. The angiotensin-1 converting enzyme I/D polymorphism is not associated with type 2 diabetesin individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol Genet Metab 2006; 88: 378-383.
17. Gunes HV, Ata N, Degirmenci I, Basaran A, Timuralp B, Dikmen M, Ustuner C, Kudaiberdieva G. Int J Clin Pract 2004; 58 (9): 838-843.
18. Hennes MM, O'shaughnessy IM, Kelly TM, LaBelle P, Egan BM, Kissebah AH. Insulin resistant lipolysis in abdominally obese hyper tensive individuals: role of the renin-angio tensin system. Hypertension 1996; 28: 120-126.
19. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ et al.Increased frequency of angiotensin- converting enzyme DD genotype in patients with type 2 diabetes in Taiwan.Nephrol Dial Transplant. 2000; 15:1008-1013
20. Appel LJ, Rizk HH, Helmy S, Mosley J, Ashour Z, El-Aroussy W, Roccella E, Whelton P. Cardiovascular risk factors in normotensive and hypertensive Egyptians. J Hypertens 2001; 19 (11): 1933-1940.
21. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system in the heart. Curr Hypertens Rep 2009; 11 (2): 104-110.
22. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens 2006; 24 (3): 413-422.
23. Lawes CM, Vander Hoorn S, Rodgers A. International Society of Hypertension Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371 (9623): 1513-1518.
24. Lee YJ, Tsai JCR. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization defi nition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25 (6): 1002-1008.
25. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997; 99: 1585-1595.
26. Nikzamir A, Nakhjavani M, Golmohamadi T, Dibai L. Association of Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism with Metabolic Syndrome in Iranians with Type 2 Diabetes Mel-litus. Arch Iranian Med 2008; 11 (1): 3-9.
27. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witte-man JC, Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Drugs 2004; 64 (22): 2537-2565.
28. Singh PP, Naz I, Gilmour A, Singh M, Mastana S. Association of APOE (Hha1) and ACE (I/D) gene polymorphism with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract 2006; 74: 95-102.
29. Sousa RM, Ferri CP, Acosta D, Albanese E, Guerra M, Huang Y, Jacob KS, Jotheeswaran AT, Rodriguez JJ, Pichardo GR, Rodriguez MC, Salas A, Sosa AL, Williams J, Zuniga T, Prince M. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet 2009; 28: 1821-1830.
30. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Sou-brier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk. J Hypertens 1997; 15: 1579-1592.
31. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ et al. The D allele of the ACE I/D common gene variant is associated with type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005; 84: 83-89.
32. Ueda S, Elliott HL, Morton JJ, Connell JM. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotyp (DD) for angiotensin-converting enzyme. Hypertension. 1995; 25: 1266-1269.